Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-23-000035

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Porter Derrell Director 2023-06-06 Grant or award · Stock Option (right to buy) +25,000 25,000 D
Loading xslF345X04/wk-form4_1686174215.xml…